One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕

12 December 2017

5366

Kazatchkine appointed UNAIDS Special Adviser

Kazatchkine appointed UNAIDS Special Adviser

Michel Kazatchkine appointed UNAIDS Special Adviser on HIV, Tuberculosis and Hepatitis C in Eastern Europe and Central Asia.

11 December 2017

5069

New hepatitis C therapy approved in UK

New hepatitis C therapy approved in UK

Maviret (Glecaprevir-pibrentasvir) has been recommended for adults with chronic hepatitis C. The treatment is an additional option suitable for all genotypes, with or without scarring of the liver, and in people who are untreated or have been treated before with interferon-based ...

11 December 2017

5054

Grantmaking for HIV Totaled a Record $680 Million

Grantmaking for HIV Totaled a Record $680 Million

Global philanthropic support for HIV/AIDS initiatives totaled a record $680 million in 2016. The top twenty funders accounted for 87 percent of 2016 resources. The top recipient of country-level philanthropic funding for HIV/AIDS initiatives was the U.S.

11 December 2017

4777

UNAIDS and IOM signed a partnership agreement

UNAIDS and IOM signed a partnership agreement

UNAIDS and the International Organization for Migration signed a new cooperation agreement to promote access to HIV prevention, treatment, care and support services for migrants, mobile populations and people affected by humanitarian emergencies.

8 December 2017

5370

NIH launches HIV prevention trial of long-acting injectable cabotegravir compared with daily oral PrEP

NIH launches HIV prevention trial of long-acting injectable cabotegravir compared with daily oral PrEP

The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every eight weeks can safely ...

8 December 2017

5337

Tilda Swinton supports the groundbreaking French HIV treatment

Tilda Swinton supports the groundbreaking French HIV treatment

ICCARRE is a groundbreaking programme reducing the amount of medication required by HIV/AIDS patients during treatment. It presents a short film directed by Blanca Li and starring Tilda Swinton.

7 December 2017

4884

Higher risk sexual behaviour is associated with unawareness of HIV-positivity

Higher risk sexual behaviour is associated with unawareness of HIV-positivity

People with HIV who don't use condoms consistently are more likely to be unaware they are HIV-positive or to have a detectable viral load when their HIV infection has been diagnosed.

7 December 2017

5053

Older antiretroviral regimens raise diabetes risk in HIV-positive

Older antiretroviral regimens raise diabetes risk in HIV-positive

HIV-positive adults who initiated older formulations of antiretroviral therapy are more likely to develop type 2 diabetes than patients who initiated therapy between 2010 and 2015, according to findings from the Canadian study.

7 December 2017

4563

Smoking presents a greater risk to HIV-positive people than HIV itself

Smoking presents a greater risk to HIV-positive people than HIV itself

HIV-positive people smoke at more than twice the rate of the general population in the US. Doctors say smoking now presents a greater risk to them than HIV itself.

6 December 2017

4633

Ontario to curb prosecution of HIV non-disclosure cases

Ontario to curb prosecution of HIV non-disclosure cases

Crown attorneys will not prosecute cases of HIV-positive people who do not disclose they have HIV if they have had a “suppressed” viral load, or amount of HIV, in their blood for six months.

1...51 52 53 54 55...117